Gene · 571
Papers2,758
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,758
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nrf3: an emerging player in cancer, inflammation, and cellular homeostasis. | Mol Biol Rep | 2026 | 41838283 | PubTator, text mining | PubMed |
| A control theoretical approach to gene regulation reveals quantitative constraints for dynamic homeostasis in stochastic gene expression. | Biochim Biophys Acta Mol Basis Dis | 2026 | 41830847 | PubTator, text mining | PubMed |
| Ferroptosis-related gene BACH1 is associated with preeclampsia and shows potential as a biomarker. | BMC Pregnancy Childbirth | 2026 | 41826889 | PubTator, text mining | PubMed |
| Metabolic reprogramming in cancer: dysregulation of glucose, lipid, and amino acid pathways and therapeutic opportunities. | Mol Biomed | 2026 | 41806079 | PubTator, text mining | PubMed |
| β-Cryptoxanthin Confers Radioprotection against Intestinal Injury via NRF2-Mediated Antioxidant Response and Gut Microbiota Reprogramming. | Int J Biol Sci | 2026 | 41800256 | PubTator, text mining | PubMed |
| Role of the RBMS Family in Different Cancers and Research Progress. | Int J Med Sci | 2026 | 41799752 | PubTator, text mining | PubMed |
| A multi-omic approach reveals iron availability influences cell fate fidelity. | NPJ Metab Health Dis | 2026 | 41792465 | PubTator, text mining | PubMed |
| Statin-Mediated Modulation of Nrf2 Signaling: Mechanisms and Therapeutic Implications in Atherosclerosis. | Rev Cardiovasc Med | 2026 | 41789331 | PubTator, text mining | PubMed |
| From mechanism to clinic: a panoramic perspective on targeting HMOX1 to overcome drug resistance. | J Cancer Res Clin Oncol | 2026 | 41786997 | PubTator, text mining | PubMed |
| Ferroptosis and cuproptosis in head and neck squamous cell carcinoma: interconnected mechanisms and therapeutic implications. | Front Pharmacol | 2026 | 41769686 | PubTator, text mining | PubMed |
| Single-cell multi-omic techniques highlight the diverse composition and intercellular interactions of the vestibular schwannoma tumor microenvironment. | Neurooncol Adv | 2026 | 41769413 | PubTator, text mining | PubMed |
| Obstructive sleep apnea and lung cancer: molecular underpinnings and clinical translational prospects. | Front Cell Dev Biol | 2026 | 41768993 | PubTator, text mining | PubMed |
| Crosstalk between mitophagy and breast cancer: mechanisms of action and clinical applications. | J Cancer Res Clin Oncol | 2026 | 41764124 | PubTator, text mining | PubMed |
| Proteasomal control of transcription factors: mechanisms, regulation and dysregulation. | Cell Mol Life Sci | 2026 | 41764121 | PubTator, text mining | PubMed |
| BACH1-mediated transcriptional repression of pro-angiogenic factors drives angiogenic impairment in hypertension. | Front Cardiovasc Med | 2026 | 41756515 | PubTator, text mining | PubMed |
| Reprogramming tumor immunity through APOBEC3s-mediated mutagenesis: from genome instability to immune checkpoint interactions. | Front Immunol | 2026 | 41756300 | PubTator, text mining | PubMed |
| Plant-Derived Bioactive Compounds in Inflammation-Related Cancers: Mechanisms and Therapeutic Potential. | Plants (Basel) | 2026 | 41754282 | PubTator, text mining | PubMed |
| BACH1-CHAC1-Glutathione Axis Aggravates Myocardial Ischemia-Reperfusion Injury by Enhancing Ferroptosis and Oxidative Stress. | Antioxidants (Basel) | 2026 | 41750596 | PubTator, text mining | PubMed |
| Chromatin Remodeling in VSMC Phenotype Switching During Vascular Remodeling: From Mechanism to Therapeutic Potential. | Biomolecules | 2026 | 41750335 | PubTator, text mining | PubMed |
| The Role of Raf Kinase Inhibitor Protein (RKIP) in HER2+ Breast Cancer Immune Evasion. | Cells | 2026 | 41744762 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/571/papers?page=3